(Medical Xpress)—Researchers in Australia have uncovered what they describe as differences in brain behavior for people diagnosed with either bipolar disorder (BP) or borderline personality disorder (BPD). As they describe ...
Molecular markers found in cancer cells that have spread from a primary tumor to a limited number of distant sites can help physicians predict which patients with metastatic cancer will benefit from aggressive, targeted radiation ...
Dec 13, 2011
0
0
Men are four times more likely to develop liver cancer compared to women, a difference attributed to the sex hormones androgen and estrogen. Although this gender difference has been known for a long time, the molecular mechanisms ...
Jan 19, 2012
0
0
The first report of the presence of alternative lengthening of telomeres (ALT) in cancers arising from the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung was published today in The American Journal ...
Sep 1, 2011
0
0
In a study recently published in Cancer Research, Van Andel Research Institute (VARI) researchers found a protein that could help predict the spread of the head and neck cancer nasopharyngeal carcinoma (NPC); this protein ...
Jun 14, 2011
0
0
A new strategy that takes advantage of ovarian cancer's reliance on folate appears to give relapse patients extra months of life with few side effects, researchers say.
Oct 28, 2011
0
0
German researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy.
May 5, 2011
0
0
A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for the first time, that ...
Feb 13, 2012
0
0
Scientists have shown a molecular chaperone is working like a waste management company to collect and detoxify high levels of toxic amyloid beta peptide found in Alzheimer's disease.
Jun 20, 2011
0
0
Kansas State University's Sherry Fleming is investigating the factor that initiates the immune system's "drama queen": the one responsible for intestinal cell damage after hemorrhage.
Aug 8, 2011
1
0
